2026年2月28日是第19个国际罕见病日，今年的主题"不止罕见"。 与此同时，国家卫健委依托国家医学中心和区域医疗中心，加强对罕见病等疑难复杂疾病的诊疗能力建 设，将MDT明确为解决误诊、延迟诊断的重要工具。 据记者不完全梳理，从2025年至今，北京清华长庚医院、北京大学第一医院、北京天坛医院、香港大学 深圳医院、山东大学第二人民医院等超过40家医疗机构建立了罕见病相关诊疗中心，普遍提供罕见病 MDT服务。 据北京病痛挑战公益基金会联合弗若斯特沙利文联合发布的《2026罕见病行业趋势观察报告》（下 称"报告"），中国人群中已知的罕见病逾4000种，罕见病患者规模约2000万，涉及大量家庭和长期医疗 需求。这也意味着，从疾病谱特征和患者规模来看，罕见病在中国同样并非边缘性医疗问题，并在多部 门协同推进下，已从单一医疗问题拓展为涵盖科研、产业、监管与支付的综合性公共议题。 2025年，中国全年共批准罕见病用药约48款，超过17款来自中国企业。在这些科研成果加速转化为临床 可及治疗选择的同时，罕见病确诊难的问题也正加速破局。 患者平均诊断时间从四年缩短至四周 身体不可控制地发胖，血压出现了问题，走路时会在没有外力 ...

2025年共批准罕见病用药约48款。 2026年2月28日是第19个国际罕见病日，今年的主题"不止罕见"。 据北京病痛挑战公益基金会联合弗若斯特沙利文联合发布的《2026罕见病行业趋势观察报告》（下 称"报告"），中国人群中已知的罕见病逾4000种，罕见病患者规模约2000万，涉及大量家庭和长期医疗 需求。这也意味着，从疾病谱特征和患者规模来看，罕见病在中国同样并非边缘性医疗问题，并在多部 门协同推进下，已从单一医疗问题拓展为涵盖科研、产业、监管与支付的综合性公共议题。 2025年，中国全年共批准罕见病用药约48款，超过17款来自中国企业。在这些科研成果加速转化为临床 可及治疗选择的同时，罕见病确诊难的问题也正加速破局。 患者平均诊断时间从四年缩短至四周 由于早期临床表型多且不典型，小陈在病友群中发现，像她一样忽视疾病、走错科室或被医生误诊的情 况，并不少见。罕见病患者的诊疗路径，往往始于反复、非特异性的症状出现，却止于漫长的误诊与延 迟确诊。 近年来，医疗机构对于罕见病诊疗的规范化培训、多项指南发布以及基因检测技术、多学科诊疗 （MDT）模式的普及，显著缩短了罕见病患者确诊时间。 2025年《国家医疗质量安 ...

Group 1 - The article highlights the approval of ZEGFROVY® (Shuwotini Tablets) by the FDA, marking it as the first independently developed innovative drug from China approved in the U.S. for treating advanced non-small cell lung cancer with EGFR exon20 insertion mutations [3][4] - The drug received priority review and represents a significant breakthrough in targeting difficult-to-treat mutations, showcasing China's capabilities in drug innovation [3] - The article also discusses the approval of a combination drug by Lipin Pharmaceutical for treating moderate to severe Alzheimer's disease, which is the first to successfully challenge original patents under the Paragraph IV process in the U.S. [4][5] Group 2 - A study on the domestic robotic telesurgery system, Jingfeng®, was published in a prestigious international journal, demonstrating a 100% success rate in remote surgeries conducted between hospitals located 450 to 2200 kilometers apart [6][8] - The research indicates significant advancements in China's high-end medical equipment and smart healthcare, marking a milestone in the clinical application of remote surgery technology [8] Group 3 - The article mentions the inclusion of North Chip Medical's LotosPFA™ system in the Late-Breaking Clinical Trials at the ESC Congress 2025, highlighting its innovative approach to non-thermal ablation technology [11][12] - The system's design allows for safer procedures with minimal muscle contraction and reduced bubble formation during ablation, enhancing operational efficiency [11][12] Group 4 - The launch of multiple AI models in healthcare by Shenzhou Medical, including a pediatric rare disease AI model and a brain hemorrhage AI model, aims to address significant challenges in diagnosing and treating rare diseases [18][20] - The "Nezha·Lingtong" model focuses on connecting various stakeholders in pediatric healthcare, while the "Brain Ruikang" model utilizes extensive clinical data to provide personalized treatment pathways [20][22] Group 5 - Sequoia China has invested in over 200 healthcare companies with distinctive technological features and high growth potential, covering various sectors including innovative drugs and digital healthcare [24]

Economic Development - Wuhan's GDP has reached 2 trillion yuan in 2023, marking a significant milestone since it first surpassed 1 trillion yuan in 2014, demonstrating strong economic resilience despite challenges like the pandemic [1] - The city has maintained its position among the top ten cities in China in terms of economic output, showcasing its robust industrial foundation and growing advantageous industries [1] Technological Innovation - Wuhan's optical electronics industry has showcased its commitment to innovation with the launch of nine new technology products in various fields, including AI and industrial manufacturing [2] - The city has attracted numerous global enterprises, with 310 Fortune 500 companies investing in Wuhan, reflecting confidence in its technological and talent resources [3] Urban Planning and Infrastructure - The State Council approved Wuhan's land spatial planning, positioning it as a central city in the midwest, emphasizing its role as a hub for economic, technological, and trade activities [3] - Over the past decade, Wuhan has developed a comprehensive metro network of 12 lines spanning 518 kilometers, facilitating daily commutes for over 4 million passengers [20] Smart City Initiatives - Wuhan is advancing towards a "smart city" model, integrating AI technologies in healthcare and community management, enhancing service efficiency and public safety [6][7] - The city has implemented smart traffic systems that improve traffic flow and safety through real-time data integration [6] Community and Social Development - The emergence of a new citizen demographic in Wuhan has transformed them into active participants in urban development, contributing to the city's vibrancy and cultural diversity [11] - The city has seen an increase in community-driven initiatives, such as smart community management and AI-assisted elder care, enhancing the quality of life for residents [7] Environmental Sustainability - Wuhan has focused on integrating natural beauty into urban development, creating ecological parks and green spaces that promote harmony between urban life and nature [17][18] - The East Lake Greenway has expanded to 105 kilometers, enhancing recreational opportunities and improving local water quality [18] Cultural and Recreational Growth - The city has developed new cultural and recreational spaces, such as outdoor movie venues and community cafes, enriching the urban lifestyle and fostering social interactions [13][14] - The revitalization of historical sites and the introduction of innovative leisure activities have contributed to a vibrant urban atmosphere [14]